The TP53 "rs 1042522″ Polymorphism and its association with precancerous cervical lesions progression among Tunisian women
Related Experiment Video
Updated: Sep 17, 2025

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
Zeineb Ben Jemia1, Emna Fehri1, Monia Ardhaoui1
1Laboratory of Molecular Epidemiology and Experimental Pathology (LR16IPT04), Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia; Department of Human and Experimental Pathology, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Abstract:
The etiological agent of cervical cancer is the infection with High- risk Human Papillomavirus. The oncoproteins E6 and E7 are responsible for the pathogenicity of this virus. The HR-HPV E6 protein binds to the tumor suppressor protein p53 via the E6AP ubiquitin ligase, inducing p53's ubiquitination and subsequent degradation by the proteasome. In this study, we investigate the association between TP53 rs1042522 polymorphism and the risk of cervical cancer among women in Tunisia and its potential role in the progression of cervical intraepithelial neoplasia. A total of hundred and eight cases including ninety-eight swabs and ten tissue samples were collected, between April 2023 and April 2024, from female participants addressed to the Pathology Department of the Pasteur Institute for HPV screening. Sequencing analysis identified three rs1042522 genotypes corresponding to wild (CC), and two mutant types, GG and CG. We found that women exhibiting mutant genotypes (CG and GG) had increased risk to cervical intraepithelial lesion progression. Interestingly, almost all patients diagnosed with cervical cancer had the mutated genotype. The association between TP53 rs1042522 and the development of cervical intraepithelial neoplasia was significant, P = 0.037; P < 0.05. Our results suggest this polymorphism as a potential biomarker linked to the progression of cervical precancerous lesions in the Tunisian women.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)